James Bell;David Spring;Prashant Bhimrao Kapadnis;Robin Hiley;Robert Glen
发明人:
Prashant Bhimrao Kapadnis,Robert Glen,Robin Hiley,James Bell,David Spring
申请号：
US13578796
公开号：
US20130053372A1
申请日:
2011.02.15
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor IB (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.
